Results 171 to 180 of about 21,257,823 (383)

Calibration and Validation of a Distributed Energy–Water Balance Model Using Satellite Data of Land Surface Temperature and Ground Discharge Measurements [PDF]

, 2013
Chiara Corbari, Marco Mancini
openalex   +1 more source

Global analyses of sea surface temperature, sea ice, and night marine air temperature since the late nineteenth century

, 2003
N. Rayner, D. Parker, E. B. Horton, C. Folland, L. Alexander, D. Rowell, Elizabeth C. Kent, A. Kaplan   +7 more
semanticscholar   +1 more source

KinectFusion: Real-time dense surface mapping and tracking

2011 10th IEEE International Symposium on Mixed and Augmented Reality, 2011
Richard A. Newcombe, S. Izadi, Otmar Hilliges, D. Molyneaux, David Kim, A. Davison, Pushmeet Kohli, J. Shotton, Steve Hodges, A. Fitzgibbon   +9 more
semanticscholar   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Distributions of concentrations of bisphenol A in North American and European surface waters and sediments determined from 19 years of monitoring data

, 2018
Charles A. Staples, Nelly van der Hoeven, Kathryn E. Clark, Ellen Mihaich, Jan Woelz, Steven G. Hentges   +5 more
openalex   +1 more source

Numerical study of ultrafast dynamics of femtosecond laser-induced periodic surface structure formation on noble metals [PDF]

, 2007
Jincheng Wang, Chunlei Guo
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Bond competition and phase evolution on the IrTe2 surface [PDF]

, 2014
Qing Li, Wenzhi Lin, Jiaqiang Yan, Xin Chen, Anthony G. Gianfrancesco, David J. Singh, David Mandrus, Sergei V. Kalinin, Minghu Pan   +8 more
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Seasonally variable relationships between surface water temperature and inflow in the upper San Francisco Estuary

, 2022
Samuel M. Bashevkin, Brian Mahardja
openalex   +1 more source